Researchers at Peking University have discovered that a filamentous gut fungus, Fusarium foetens, can reverse metabolic ...

Dr. Falk Pharma’s norucholic acid (NCA) drug has demonstrated potential in a Phase III trial for primary sclerosing ...

Dr. Falk Pharma, a research-based pharmaceutical company specializing in digestive and metabolic medicine, today announced ...

The primary analysis conducted after 96 weeks of treatment showed that NCA led to a statistically significant achievement of the trial’s primary endpoint, which was defined as partial normalisation of ...

Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is ...

Here, we deployed a multidimensional approach to unravel the T-cell functional landscape in primary colorectal cancers (CRC) and liver metastases ... LA, FP and CD performed pathology analyses on ...

Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection ...

Liver cancer survival rates reflect income disparities. ScienceDaily . Retrieved May 5, 2025 from www.sciencedaily.com / releases / 2025 / 05 / 250505121909.htm ...

Bile duct cancer, medically known as cholangiocarcinoma, is a cancer that grows in tubes connecting the liver, gallbladder and the intestine. The aggressive disease strikes about 3,100 people i ...

Furthermore, the liver is a common organ for metastases originating from other primary cancer, significantly impacting treatment outcomes. Aimed at addressing these clinical challenges ...